Mirae Asset Global Investments’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,580
| Closed | -$3.02K | – | 1593 |
|
|
2024
Q3 | $3.02K | Buy |
2,580
+452
| +21% | +$529 | ﹤0.01% | 1533 |
|
|
2024
Q2 | $2.36K | Sell |
2,128
-29,424
| -93% | -$32.7K | ﹤0.01% | 1506 |
|
|
2024
Q1 | $239K | Buy |
+31,552
| New | +$239K | ﹤0.01% | 2194 |
|
|
2023
Q4 | – | Sell |
-32,807
| Closed | -$225K | – | 2521 |
|
|
2023
Q3 | $225K | Buy |
32,807
+1,762
| +6% | +$12.1K | ﹤0.01% | 2248 |
|
|
2023
Q2 | $322K | Sell |
31,045
-47
| -0.2% | -$487 | ﹤0.01% | 2155 |
|
|
2023
Q1 | $252K | Sell |
31,092
-43
| -0.1% | -$348 | ﹤0.01% | 2247 |
|
|
2022
Q4 | $490K | Buy |
31,135
+4,423
| +17% | +$69.7K | ﹤0.01% | 1903 |
|
|
2022
Q3 | $420K | Buy |
26,712
+10,467
| +64% | +$165K | ﹤0.01% | 1975 |
|
|
2022
Q2 | $227K | Buy |
+16,245
| New | +$227K | ﹤0.01% | 2103 |
|